BCC
UTMD icon

Bridge City Capital’s Utah Medical Products UTMD Stock Holding History

Bridge City Capital’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$452K Buy
7,291
+407
+6% +$25.6K 0.13% 99
2025
Q4 		$385K Buy
6,884
+1,254
+22% +$72.7K 0.11% 101
2025
Q3 		$355K Buy
5,630
+646
+13% +$38.2K 0.09% 98
2025
Q2 		$284K Sell
4,984
-127
-2% -$6.91K 0.08% 104
2025
Q1 		$286K Sell
5,111
-162
-3% -$9.71K 0.09% 99
2024
Q4 		$324K Buy
5,273
+9
+0.2% +$582 0.09% 102
2024
Q3 		$352K Hold
5,264
– – 0.1% 106
2024
Q2 		$352K Buy
5,264
+709
+16% +$48.3K 0.12% 105
2024
Q1 		$324K Buy
4,555
+1,379
+43% +$103K 0.12% 104
2023
Q4 		$267K Buy
+3,176
New +$263K 0.1% 102

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridge City Capital's UTMD Position: Q1 2026 in Review

Bridge City Capital increased its Utah Medical Products (UTMD) stake by 5.9% in Q1 2026, buying an estimated $25.6K and bringing the position to 7,291 shares worth $452K. The position accounts for 0.13% of the portfolio, ranked #99.

Bridge City Capital first reported a position in UTMD in Q4 2023 and has held it in 10 quarters since. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Bridge City Capital held 7,291 shares of Utah Medical Products worth $452K as of Q1 2026.
  • Bridge City Capital bought 407 Utah Medical Products shares in Q1 2026, an estimated $25.6K.
  • Utah Medical Products made up 0.13% of Bridge City Capital's portfolio in Q1 2026, its #99 holding.
  • Bridge City Capital first reported a position in Utah Medical Products in Q4 2023 and has held it in 10 quarters since.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Bridge City Capital's 13F filing for Q1 2026, filed 13 May 2026.